Medical Writing Vaccines and Immunotherapies Medical Communications

Volume 27, Issue 1 - Vaccines and Immunotherapies

Medical Communications


In this first issue of 2018, I’m delighted to introduce an excellent article from one of EMWA’s newest Workshop Leaders, John Dixon. Although John is new to teaching at EMWA, he’s extremely experienced in his field – or, more correctly, fields! John qualified in medicine and initially trained as a surgeon before becoming a GP. Since 2003, John has completed an MBA and spent 5 years as Director of Medical Communications at InterComm International Ltd, becoming a healthcare communications consultant and trainer in scientific writing in 2013.


  1. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737–8.
  2. Plavén-Sigray P, Matheson GJ, Schiffler BC, Thompson WH. The readability of scientific texts is decreasing over time. eLife. 2017;6:e27725.
  3. Hayes DP. The growing inaccessibility of science. Nature. 1992;356:739–40.
  4. Wilson MJ, Ramey TL, Donaldson MR, Germain RR, Perkin EK. Communicating science: Sending the right message to the right audience. FACETS. 2016;1:127–37.
  5. Suber P. Open Access. Cambridge, MA: MIT Press; 2012.
  6. Terry S. In the public interest. Open access. College & Research Libraries News. 2005;66(7):522–5.
  7. Hartley J. Three ways to improve the clarity of journal abstracts. Brit J Educ Psychol. 1994;64:331–43.
  8. Weeks WB, Wallace AE. Readability of British and American medical prose at the start of the 21st century. BMJ. 2002;325:1451–2.
  9. Hochhauser M. Readability of British and American medical prose. Why are unreadable articles still being written? BMJ. 2003;326:711.
  10. Smith K, Buchanan P, McDonald P. How easy is it for a lay audience to read medical journals? A survey of the readability scores of a sample of research papers on diabetes. The Lancet. 2017;390:S82.
  11. Kuehne LM, Olden JD. Opinion: Lay summaries needed to enhance science communication. P Natl Acad Sci USA. 2015;112:3585–6.
  12. Teplitskiy M, Lu G, Duede E. Amplifying the impact of open access: Wikipedia and the diffusion of science. J Assoc Inf Sci Tech. 2017;68:2116–27.
  13. Knight J. Scientific literacy: Clear as mud. Nature. 2003;423:376–8.
  14. Ludbrook J. Writing intelligible English prose for biomedical journals. Clin Exp Pharmacol P. 2007;34:508–14
  15. Wager E, Middleton P. Effects of technical editing in biomedical journals: a systematic review. JAMA. 2002;287:2821–4.
  16. Hall JC. The readability of original articles in surgical journals. ANZ J Surg. 2006;76:68–70.
  17. Readable.IO. 2018. [cited 2018 Jan 02]. Available from:
  18. Hemingway Editor. 2018. [cited 2018 Jan 02]. Available from:



Vaccines and immunotherapies
President's Column
A history of EMWA
An introduction to vaccines and immunotherapies
Immuno-oncology: Harnessing our immune system to fight cancer
Changing methods to assess targeted therapies in oncology
HIV vaccine clinical trials: An overview
Allergen immunotherapy in the European regulatory environment
Pharmacovigilance for vaccines and immunotherapies
Addressing vaccine hesitancy in writing
Results of the 2017 EMWA salary survey
Lay writing: Strategies for improving assent forms
The perils of the unknown: Missing data in clinical studies
Medical writing in China: Trends and opportunities
PhD student: A medical writer in the making!
News from the EMA
Medical Communications
Journal Watch
In the Bookstores
The Webscout
Teaching Medical Writing
Good Writing Practice
Medical Devices
Getting Your Foot in the Door
Entering medical communications as a non-native English speaker
Out on Our Own
Lingua Franca and Beyond

Member Login


The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board



Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: